Remocaldo, Elizabeth C.

HRN: 27-48-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CEFTRIAXONE 1G (VIAL)
02/14/2026
02/20/2026
IVTT
2g
OD
Cap-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: